Condition
Common Bile Duct Neoplasms
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07161869Not Yet Recruiting
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
NCT05678218Completed
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
NCT05945797Not ApplicableCompleted
Effects of Dexamethasone on Common Bile Duct Cannulation Time
NCT05147389CompletedPrimary
Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis
NCT02575014Not ApplicableUnknown
Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy
NCT01683240Not ApplicableCompleted
Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones
Showing all 6 trials